IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

LIONETTI, MARTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 11.171
NA - Nord America 4.922
AS - Asia 3.272
SA - Sud America 290
OC - Oceania 46
AF - Africa 26
Continente sconosciuto - Info sul continente non disponibili 7
Totale 19.734
Salva come PNG Salva come JPEG
Nazione #
DE - Germania 5.832
US - Stati Uniti d'America 4.782
GB - Regno Unito 2.166
CN - Cina 1.637
IT - Italia 887
SG - Singapore 584
SE - Svezia 556
RU - Federazione Russa 436
IN - India 248
TR - Turchia 228
NL - Olanda 211
KR - Corea 195
FR - Francia 191
BR - Brasile 189
UA - Ucraina 185
IE - Irlanda 182
FI - Finlandia 138
CA - Canada 125
EU - Europa 122
HK - Hong Kong 98
ID - Indonesia 79
CO - Colombia 64
PL - Polonia 54
JP - Giappone 50
DK - Danimarca 47
BE - Belgio 45
ES - Italia 44
AU - Australia 40
CH - Svizzera 36
GR - Grecia 29
VN - Vietnam 28
RO - Romania 25
AT - Austria 24
CZ - Repubblica Ceca 21
AR - Argentina 16
PT - Portogallo 15
IR - Iran 13
PH - Filippine 11
TH - Thailandia 11
TW - Taiwan 11
SA - Arabia Saudita 9
HU - Ungheria 8
MX - Messico 8
MY - Malesia 8
PK - Pakistan 7
AE - Emirati Arabi Uniti 6
AL - Albania 6
CL - Cile 6
NZ - Nuova Zelanda 6
BG - Bulgaria 5
EG - Egitto 5
IL - Israele 5
JO - Giordania 5
NO - Norvegia 5
PE - Perù 5
AM - Armenia 4
AZ - Azerbaigian 4
BD - Bangladesh 4
EC - Ecuador 4
HR - Croazia 4
MA - Marocco 4
RS - Serbia 4
UZ - Uzbekistan 4
ZA - Sudafrica 4
BY - Bielorussia 3
CR - Costa Rica 3
GE - Georgia 3
LI - Liechtenstein 3
LV - Lettonia 3
MU - Mauritius 3
QA - Qatar 3
SC - Seychelles 3
VE - Venezuela 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BO - Bolivia 2
CY - Cipro 2
KZ - Kazakistan 2
LB - Libano 2
LU - Lussemburgo 2
OM - Oman 2
TN - Tunisia 2
BH - Bahrain 1
BZ - Belize 1
DZ - Algeria 1
GA - Gabon 1
IQ - Iraq 1
IS - Islanda 1
KE - Kenya 1
KG - Kirghizistan 1
KH - Cambogia 1
KW - Kuwait 1
LK - Sri Lanka 1
MD - Moldavia 1
MN - Mongolia 1
NG - Nigeria 1
NI - Nicaragua 1
NP - Nepal 1
PA - Panama 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 19.847
Salva come PNG Salva come JPEG
Città #
Frankfurt am Main 4.601
Southend 1.931
Chandler 443
Singapore 392
Seattle 376
Beijing 370
Fairfield 288
Wilmington 285
Milan 283
Princeton 250
Ashburn 245
Houston 192
Dublin 170
Council Bluffs 154
Mountain View 150
Woodbridge 149
Dearborn 148
Nanjing 133
Jacksonville 132
Ann Arbor 121
Redmond 119
Cambridge 104
Shanghai 96
Toronto 85
Des Moines 79
Berlin 74
Somerville 74
Andover 73
Hong Kong 69
Sakarya 68
Boardman 65
Serra 65
Jakarta 63
Bengaluru 61
Bogotá 60
Jinan 60
Hangzhou 56
Redwood City 51
Shenyang 51
Changsha 48
Eitensheim 46
Phoenix 46
Saint Petersburg 46
Cangzhou 42
Guangzhou 42
Santa Clara 42
Nanchang 41
Helsinki 39
The Dalles 33
Kiez 32
Tianjin 32
Fuzhou 31
Hanover 29
Hebei 29
New York 29
Grafing 28
Zhengzhou 28
Warsaw 27
Athens 25
Seoul 25
Naples 24
Falls Church 23
Hamburg 22
London 22
San Diego 21
Bitonto 20
Los Angeles 20
Silver Spring 20
Brussels 19
Hefei 18
São Paulo 18
Kunming 17
Odernheim 17
Wuhan 17
Roxbury 15
Sunnyvale 15
Nürnberg 14
Taiyuan 14
Bologna 13
Chicago 13
Jiaxing 13
Munich 13
Rochester 13
Rome 13
Stockholm 13
Würzburg 13
Changchun 12
Istanbul 12
Bari 11
Bern 11
Bodio Lomnago 11
Bühl 11
Chengdu 11
Kent 11
Ottawa 11
Vienna 11
Auburn Hills 10
Central 10
Medford 10
Nuremberg 10
Totale 13.518
Salva come PNG Salva come JPEG
Nome #
Utilizing next-generation sequencing in the management of multiple myeloma 1.243
Clinical-biological characterization of variant B chronic lymphocytic leukemia, characterized by a mantle cell lymphoma-like immunophenotype, t(11;14)(q13;q32) negative 452
BIOLOGICAL AND CLINICAL RELEVANCE OF MIRNA EXPRESSION SIGNATURES IN PRIMARY PLASMA CELL LEUKEMIA 319
Whole-exome sequencing of primary plasma cell leukemia discloses heterogeneous mutational patterns 278
A distinctive trascriptional profile characterizes the chromosome 17p loss in B-cell chronic lymphocytic leukemia 271
An integrative genomic approach reveals coordinated expression of intronic miR-335, miR-342, and miR-561 with deregulated host genes in multiple myeloma 266
Insulin Growth Factor 1 Receptor Expression Is Associated with NOTCH1 Mutation, Trisomy 12 and Aggressive Clinical Course in Chronic Lymphocytic Leukaemia 266
Circulating tumor DNA as a liquid biopsy in plasma cell dyscrasias 263
A compendium of DIS3 mutations and associated transcriptional signatures in plasma cell dyscrasias 243
The expression pattern of small nucleolar and small cajal body-specific RNAS characterizes distinct molecular subtypes of multiple myeloma 239
Analisi del numero di copie e sequenza del DNA in campioni sequenziali di melanoma alla diagnosi e recidiva=DNA copy number and whole-exome sequencing analyses in sequential myeloma samples at diagnosis and relapse 235
MicroRNA genes associated with genomic alterations or gene expression modulation contribute to enhance genetic heterogeneity in Multiple Myeloma 233
B-cell receptor configuration and adverse cytogenetics are associated to a higher risk of autoimmune hemolytic anemia in the course of chronic lymphocytic leukemia 232
Long non-coding RNAs in normal and malignant hematopoiesis 232
Impact of Host Genes and Strand Selection on miRNA and miRNA* Expression 226
Synthetic miR-34a mimics as a novel therapeutic agent for Multiple Myeloma : in vitro and in vivo evidence 223
Deregulation of MIR-221/222 cluster affects P27 expression in multiple myeloma 221
A novel fish-based normalization procedure for whole genome microarrays detecting accurate local copy numbers : application to multiple myeloma 219
Biological and clinical relevance of miRNA expression signatures in primary plasma cell leukemia 215
Integrative genomic analysis of trisomy 12 abnormality in B-cell chronic lymphocytic leukemia 212
Molecular classification and pharmacogenetics of primary plasma cell leukemia: an initial approach toward precision medicine 208
Molecular spectrum of TP53 mutations in plasma cell dyscrasias by next generation sequencing: an Italian cohort study and overview of the literature 207
Prevalence of ras gene mutations in the context of a molecular classification of multiple myeloma 205
Genome-wide analysis of primary plasma cell leukemia identifies recurrent imbalances associated with changes in transcriptional profiles 203
Molecular spectrum of BRAF, NRAS and KRAS gene mutations in plasma cell dyscrasias : implication for MEK-ERK pathway activation 203
Molecular and transcriptional characterization of 17P loss in B-cell chronic lymphocytic leukemia 199
Functional impact of genomic complexity on the transcriptome of Multiple Myeloma 197
Analysis of Stereotyped IGHV distribution in a series of 1133 chronic lymphocytic leukemia patients : the experience of a multicenter Italian Study Group 196
Clonal evolution in therapy-related neoplasms 195
A SNP microarray and FISH-based procedure to detect allelic imbalances in multiple myeloma : an integrated genomics approach reveals a wide gene dosage effect 194
Biological and Clinical Relevance of Surrogate Markers of IgVH Mutational Status in B-Cell Chronic Lymphocytic Leukemia 194
Integrative genomic analysis of primary plasma cell leukemia revealed strong gene and microrna dosage effect 194
Application of next-generation sequencing for the genomic characterization of patients with smoldering myeloma 194
The investigation of genomic profiles in plasma cell leukemias by means of an integrative microarray approach 192
Integrative genomic approach identifies deregulated micrornas in human myeloma cell lines 190
The investigation of genomic profiles in primary plasma cell leukemias by means of an integrative microarray approach 189
miR-29b sensitizes multiple myeloma cells to bortezomib-induced apoptosis through the activation of a feedback loop with the transcription factor Sp1 189
Clinico-biological characterization of a subset of variant B-CLL, defined according to a combined cytofluorimetric/fish diagnostic approach 188
Time to first treatment and P53 dysfunction in chronic lymphocytic leukaemia: results of the O-CLL1 study in early stage patients 188
A novel fish-based normalization procedure for whole genome microarrays detection accurate local copy numbers : application to multiple myeloma 187
The investigation of genomic profiles in primary plasma cell leukemias by means of an integrative microarray approach 185
Global SNP-based mapping of B-cell chronic lymphocytic leukemia reveals the role of 2p gain in predicting clinical outcome 183
Stereotyped B-cell receptor is associated with immune thrombocytopenia in CLL 183
Deregulated microrna expression patterns are associated with high-rish genetic groups in multiple myeloma 182
Global microrna expression profiling in multiple myeloma identifies deregulated patterns associated with distinct molecular groups 181
Molecular and transcriptional characterization of 17p loss in B-cell chronic lymphocytic leukemia 180
Genome-wide DNA copy number analysis by SNP arrays of B-cell chronic lymphocytic leukemia reveals the presence of novel molecular lesions 180
B-cell receptor configuration and adverse cytogenetics are associated with autoimmune hemolytic anemia in chronic lymphocytic leukemia 180
Integrative high-resolution microarrays approach in B-cell chronic lymphocytic leukemia reveals the presence of molecularly distinct subgroups in patients with 13Q deletion 179
IGHV gene analysis in chronic lymphocytic leukemia 179
Frequency and clinical relevance of coding and noncoding NOTCH1 mutations in early stage Binet A chronic lymphocytic leukemia patients 179
Gene and mirna expression profiles in plasma cell leukemias 178
High-resolution microarray characterization of the 13q14 deletion extent in B-cell chronic lymphocytic leukemia : correlation with copy number and expression levels of mir-15a/16 cluster 177
Integrative Genomic Approach Identifies Deregulated MicroRNAs in Human Myeloma Cell Lines 177
Integrative genomics analyses reveal molecularly distinct subgroups of B-cell chronic lymphocytic leukemia patients with 13q14 deletion 177
Chromosome 2p gain in monoclonal B-cell lymphocytosis and in early stage chronic lymphocytic leukemia 177
Transcriptional characterization of a prospective series of primary plasma cell leukemia revealed signatures associated with tumor progression and poorer outcome 173
Novel surrogate markers of IGVH mutational status in B-cell chronic lymphocytic leukemia 173
From integration of mirnas and genes expression profiles to reconstruction and analysis of regulatory networks 172
Deregulation of MIR-221/222 cluster affects P27 expression in multiple myeloma 172
High-throughput sequencing for the identification of NOTCH1 mutations in early stage chronic lymphocytic leukaemia: biological and clinical implications 172
Pleiotropic anti-myeloma activity of ITF2357 : inhibition of interleukin-6 receptor signaling and repression of miR-19a and miR-19b 171
Relevance of stereotyped B-cell receptors in the context of the molecular, cytogenetic and clinical features of chronic lymphocytic leukemia 171
Integrative genomic approach based on SNP-array and gene expression profiling reveals the presence of molecularly distinct subgroups in early stage b-cell chronic lymphocytic leukemia 168
Global microrna expression profiling in multiple myeloma identifies deregulated patterns associated with distinct molecular groups 167
Identification of myeloma-associated miRNA and their prognostic value : a compendium from UK MRC myeloma IX trial 167
Critical analysis of transcriptional and post-transcriptional regulatory networks in multiple myeloma 165
Identification of microRNA expression patterns and definition of a microRNA/mRNA regulatory network in distinct molecular groups of multiple myeloma 162
Clinical Monoclonal B lymphocytosis versus Rai 0 Chronic Lymphocytic Leukemia : a Comparison of Cellular, Cytogenetic, Molecular, and Clinical Features 161
Analysis of hiperdiploidy in Multiple Myeloma by fluorescence in situ hybridization. 157
Reconstruction of transcriptional regulatory networks in multiple myeloma 156
Stereotyped B-cell receptors in chronic lymphocytic leukemia : a biological and clinical compendium from a multicenter italian cohort 156
Biological and prognostic impact of APOBEC-induced mutations in the spectrum of plasma cell dyscrasias and multiple myeloma cell lines 156
Integrative genomic approach in B-cell chronic lymphocytic leukemia : definition of molecularly distinct subgroups of patients with 13Q14 deletion 153
MGUS and clonal hematopoiesis show unrelated clinical and biological trajectories in an older population cohort 152
Relevance of chromosome 2P gain in early Binet stage A chronic lymphocytic leukemia 150
Stereotyped B-cell receptors in chronic lymphocytic leukemia : a compendium from a multicenter italian cohort 149
Micro-RNA and gene expression profiling in chronic lymphocytic leukemia-like (CLL-LIKE) clinical monoclonal B lymphocytosis and RAI-0 CLL : a comparative analysis of a prospective multicenter osservational study 149
Transcriptome analysis of primary plasma cell leukemia tumors from a multicenter prospective gimena study : biological and clinical implications 148
Clinical, Morphological and Clonal Progression of VEXAS Syndrome in the Context of Myelodysplasia Treated with Azacytidine 147
Multiple myeloma post-transcriptional regulatory network reconstructed by integrated analysis of microrna and gene expression profiles 147
Single-agent Smac-mimetic compounds induce apoptosis in B chronic lymphocytic leukaemia (B-CLL) 147
Compendium of FAM46C gene mutations in plasma cell dyscrasias 147
Relevance of stereotyped B-cell receptors in the context of the molecular, cytogenetic and clinical features of CLL 145
PRO-APOPTOTIC EFFECT OF A NEW SMAC-MIMETIC ON B-CLL CELLS IN VITRO 145
Molecular and transcriptional characterization of the novel 17p11.2-p12 amplicon in multiple myeloma 145
Immune thrombocytopenia in patients with chronic lymphocytic leukemia is associated with stereotyped B-cell receptors 137
Limits and Applications of Genomic Analysis of Circulating Tumor DNA as a Liquid Biopsy in Asymptomatic Forms of Multiple Myeloma 135
Single-Cell RNA Sequencing for the Detection of Clonotypic V(D)J Rearrangements in Multiple Myeloma 134
The clinical and biological features of a series of immunophenotypic variant of B-CLL 129
Association between gene and miRNA expression profiles and stereotyped subset #4 B-cell receptor in chronic lymphocytic leukemia 129
Prospective validation of a risk score based on biological markers for predicting progression free survival in binet stage a chronic lymphocytic leukemia patients : Results of the multicenter O-CLL1-GISL study 127
CD26 expression in mature B-cell neoplasia : its possible role as a new prognostic marker in B-CLL 125
Improved risk stratification in myeloma using a microRNA-based classifier 125
DNA-demethylating and anti-tumor activity of synthetic miR-29b mimics in multiple myeloma 124
MiR-29b induces SOCS-1 expression by promoter demethylation and negatively regulates migration of multiple myeloma and endothelial cells 122
microRNAome expression in chronic lymphocytic leukemia : comparison with normal B cell subsets and correlations with prognostic and clinical parameters 122
The apobec mutational activity in multiple myeloma: from diagnosis to cell lines 117
Global methylation patterns in primary plasma cell leukemia 116
In Vitro and in Vivo Anti-tumor Activity of miR-221/222 Inhibitors in Multiple Myeloma 115
Totale 19.377
Salva come PNG Salva come JPEG
Categoria #
all - tutte 48.742
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.742
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020122 0 0 0 0 0 0 0 0 0 0 68 54
2020/20211.603 148 113 78 73 136 119 79 98 183 93 384 99
2021/20221.503 113 68 81 79 146 114 135 74 190 125 78 300
2022/20231.682 268 162 141 185 178 320 58 106 135 29 75 25
2023/20244.058 27 72 59 89 284 184 657 561 269 586 619 651
2024/20253.408 582 543 506 466 184 125 156 290 158 280 118 0
Totale 20.614